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kConFab, the Australian/New Zealand consortium for
research into families at high risk of breast and ovarian
cancer, has completed collection & recruitment of 1,421
families during the past 14 years. Biological material,
genetic, epidemiological, and psychosocial data are col-
lected from affected and unaffected, female and male
participants over the age of 18. This material is available
to peer reviewed, ethically approved and funded
research projects. At present, kConFab supplies material
to 52 research projects world-wide.
The kConFab biological repository contains blood spe-
cimens from a total of 12,340 participants and 233 best
friend controls. The standardized blood processing pro-
tocol produces plasma, non lymph, blood pellet and
white blood cell fractions. White blood cells undergo
EBV transformation which can be used by in functional
assays or as a replacement source of DNA/RNA. To
date, 1511 unique EBV cell line transformations are
available.
As of July 2011, 97% of kConFab families have had
genetic testing; identifying 35% of families with a patho-
genic, large genomic rearrangement (LGR) or splice site
mutation in either BRCA1 or BRCA2. An additional 11%
of families carry unclassified variants in BRCA1 or
BRCA2; with a further 0.7 % with mutations in the
ATM, CHEK2 or TP53 genes. Of the 1,924 female parti-
cipants who harbour the germline mutation, 66% are
affected with breast or ovarian cancer.
kConFab has collected a total of 898 fresh tissue col-
lections, including prophylactic mastectomy and
oophorectomy specimens; and has a large collection of
archival specimens. The tissue bank consists primarily
of breast and ovarian tissue (tumour and normal), with
a small proportion of other tissues. Tumour tissue com-
prises 27% of the bank. Following collection, a full
research pathology review is conducted, wherein fea-
tures such percentage tumour, normal epithelial, lymph
and necrotic components are scored.
kConFab has constructed a total of 23 tissue microar-
rays (TMAs) (both sporadic and familial tumours) from
our tissue bio bank. Where possible, tumour is matched
to normal from the same archival block.
kConFab are currently working to supplement our
glass slide archive with a digital slide repository. This
will provide researchers with high resolution, high qual-
ity whole slide digital images for ease of transport, sto-
rage, review and analysis. Currently we have >1000
slides scanned for more than 600 participants.
The kConFab resource enables researchers to answer
important questions relating to familial aspects of breast
cancer. Information about the kConFab resource and
the application process is available on the web site
(http://www.kconfab.org).
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